Windtree Therapeutics Inc (NASDAQ:WINT)’s traded shares stood at 4.45 million during the latest session, with the company’s beta value hitting 0.66. At the last check today, the stock’s price was $3.19, to imply an increase of 7.59% or $0.23 in intraday trading. The WINT share’s 52-week high remains $27.00, putting it -746.39% down since that peak but still an impressive 13.79% since price per share fell to its 52-week low of $2.75. The company has a valuation of $1.63M, with an average of 1.8 million shares in intraday trading volume over the past 10 days and average of 1.21 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Windtree Therapeutics Inc (WINT), translating to a mean rating of 3.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give WINT a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Windtree Therapeutics Inc (NASDAQ:WINT) trade information
After registering a 7.59% upside in the latest session, Windtree Therapeutics Inc (WINT) has traded red over the past five days. The 5-day price performance for the stock is 13.93%, and -68.74% over 30 days. With these gigs, the year-to-date price performance is -75.35%. Short interest in Windtree Therapeutics Inc (NASDAQ:WINT) saw shorts transact 0.11 million shares and set a 0.47 days time to cover.
Windtree Therapeutics Inc (WINT) estimates and forecasts
Looking at statistics comparing Windtree Therapeutics Inc share performance against respective industry, we note that the company has outperformed competitors. Windtree Therapeutics Inc (WINT) shares are -49.02% down over the last 6 months, with its year-to-date growth rate higher than industry average at 97.47% against 17.20%.
WINT Dividends
Windtree Therapeutics Inc has its next earnings report out on 2024-Nov-07. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Windtree Therapeutics Inc (NASDAQ:WINT)’s Major holders
Windtree Therapeutics Inc insiders hold 4.01% of total outstanding shares, with institutional holders owning 8.85% of the shares at 9.22% float percentage. In total, 8.85% institutions holds shares in the company.
